Press "Enter" to skip to content

Meghalaya has no word from Centre on clinical trial of Covaxin

Shillong, Aug 1: The Meghalaya government has not received official communication from the Centre in connection with the clinical human trial of the country’s first coronavirus vaccine, Covaxin.
“The State government has not received anything official from the Centre as far as the vaccine is concerned,” DHS (MI), Dr Aman War told reporters on Saturday.
The first phase of human trial of Covaxin was completed at PGIMS Rohtak. The hospital started the trial on July 17 and around 50 volunteers enrolled for this exercise.
Clinical human trial of Covaxin, the first potential coronavirus vaccine in the country, started in Uttar Pradesh on Friday.
Rana Hospital & Trauma Centre in Uttar Pradesh was one of the 12 institutes selected by the Indian Council of Medical Research (ICMR) for clinical human trial of Covaxin.
Bharat Biotech and Zydus were granted permission for Phase I and II clinical trials of Covaxin and ZyCoV-D respectively.
The pharmaceutical companies have said that the first doses of their vaccine candidates were administered to volunteers in July.
Meanwhile Dr War emphasized the need to follow the Covid-19 protocols by wearing masks and maintain social distancing to prevent from getting infected by the virus and one has to learn to live a new normal.
“It is clear now that we have to live with the virus as the virus is coming. Taking care at home is much better than staying in hospital or corona care centre. Nearly 95 percent Covid-19 positive cases are asymptomatic. That’s why we have to accept that the virus is coming and we have to learn to live with the virus only by following the protocols. Once we learn to live, we can live normally and take care of ourselves,” Dr War said.